BMO Capital analyst Juan C. Sanabria reiterated a Buy rating on Healthpeak Properties (PEAK – Research Report) today and set a price target of $30.00. The company’s shares closed today at $27.23.
According to TipRanks, C. Sanabria is an analyst with an average return of -1.9% and a 43.60% success rate. C. Sanabria covers the Financial sector, focusing on stocks such as Welltower, Healthpeak Properties, and LTC Properties.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Healthpeak Properties with a $28.50 average price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $34.55 and a one-year low of $21.14. Currently, Healthpeak Properties has an average volume of 3.59M.
Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PEAK in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Healthpeak Properties, Inc. is a real estate investment trust, which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers. It operates through the following business segments: Senior Housing Triple-Net, Senior Housing Operating Portfolio (SHOP), Life Science, and Medical Office. The Senior Housing Triple-Net and Operating Portfolio segments manage senior housing facilities, which include independent living, assisted living and memory care facilities, care homes, and continuing care retirement communities by utilizing triple-net leases and RIDEA structures. The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Medical Office segment includes pharmacies, hospital ancillary service space, and outpatient services such as diagnostic centers, rehabilitation clinics, and day-surgery operating rooms. The company was founded in March 1985 and is headquartered in Irvine, CA.
Read More on PEAK:
- Healthpeak Properties Reports Fourth Quarter and Year Ended 2022 Results
- Healthpeak Properties Declares Quarterly Cash Dividend on Common Stock
- Healthpeak upgraded to Buy at Jefferies with stability prioritized
- Healthpeak upgraded to Buy from Hold at Jefferies
- Healthpeak downgraded to Sector Perform from Outperform at RBC Capital